The generality of a model for predicting tumor control probability from in vitro clonogenic survival considering of cancer stem-like cells, the so-called integrated microdosimetric-kinetic model, is presented by comparing the model to public data on stereotactic body radiation therapy for non-small cell lung cancer cells.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11110032 | PMC |
http://dx.doi.org/10.1016/j.adro.2023.101437 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!